Trial Profile
Assessment of antiplatelet effect after ticagrelor loading dose in ST-Segment–Elevation Myocardial Infarction patients and Non ST-segment elevation myocardial infarction patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Aug 2020
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Myocardial infarction
- Focus Pharmacodynamics
- 08 Aug 2020 Results published in the Advances in Therapy
- 05 Feb 2018 New trial record